AKT1 and glioblastoma: CK2 inhibition in xenograft GBM tumors lead to decreased activation of STAT-3, NF-κB, c-myc and AKT, and decreased EGFR expression, suggesting that CK2 controls several pro-survival and pro-proliferative signals in vivo [21,127].